Abstract Details

Title Mathematical Proof Reveals Cushing’s Triad as Diastolic Collapse: The 2:1 Ratio as a Precision Diagnostic Marker and Novel Therapeutic Target

Topic Neuro Trauma and Critical Care

Presentation(s) P6 - Poster Session 6 (5:00 PM-6:00 PM)

Poster/Presentation
Number 19-003

Objective To derive the precise hemodynamic mechanism of Cushing’s triad using fundamental physics principles and validate quantitative predictions against clinical data.

Background Cushing’s triad has been misunderstood as protective hypertension for over a century. Using de Broglie principles and energy conservation, we hypothesized that the triad represents forced hemodynamic
redistribution, not a protective reflex.

Design/Methods Mathematical analysis of cerebral hemodynamics under ICP constraints. Energy conservation equations (δP_L + δP_t ≈ 0) were applied to derive pressure relationships. Clinical validation used retrospective analysis of blood pressure patterns in TBI patients with Cushing’s triad versus IIH patients with elevated ICP.

Results Mathematical derivation reveals δSBP ≈ 2(-δDBP) with δMAP ≈ 0, predicting systolic pressure rises exactly twice the diastolic drop while MAP remains constant. Clinical validation (n=400+) confirmed
99% of cases show this 2:1 ratio (e.g., 120/80→160/60). Five mathematical conditions must be met:
ICP dominance (δP_c ≈ δP_T ), pressure opposition (δP_t = −δP_L), transverse flow failure (δmt/δmL → 0),
volume collapse (δV_t/δV_L → 0), and tissue injury. This explains why TBI at ICP 30-35mmHg triggers
the triad while IIH at 45mmHg does not. The triad originates from the compressed normal hemisphere, not injured tissue. Terminal progression shows coronary hypoperfusion at DBP<50, leading to cardiac arrest.

Conclusions Cushing’s triad represents mathematically-forced diastolic collapse with compensatory systolic rise. The 2:1 ratio provides an objective diagnostic trigger for immediate EVD placement. Understanding diastolic hypotension as primary pathology opens novel therapeutic targets: agents maintaining DBP without raising ICP, perforator-specific vasodilators, and ICP-MAP constraint breakers. This quantitative framework transforms a mysterious reflex into targetable pathophysiology with immediate applications
for automated detection systems and pharmaceutical development.

Authors/Disclosures
Joshua Mendelson, MD PRESENTER	Dr. Mendelson has nothing to disclose.
Mustafa Khan, MD (Sevaro Health Inc.)	Dr. Khan has nothing to disclose.

��ɫ��

��ɫ��